Edition:
United Kingdom

MEI Pharma Inc (MEIP.OQ)

MEIP.OQ on NASDAQ Stock Exchange Capital Market

2.14USD
7:32pm GMT
Change (% chg)

$0.03 (+1.42%)
Prev Close
$2.11
Open
$2.12
Day's High
$2.16
Day's Low
$2.05
Volume
19,042
Avg. Vol
41,135
52-wk High
$3.26
52-wk Low
$1.35

Select another date:

Wed, Nov 8 2017

BRIEF-Mei Pharma enters into at-market equity offering sales agreement

* On Nov. 8, 2017, co entered into at--market equity offering sales agreement with Stifel, Nicolaus & Company, Incorporated, as sales agent​

BRIEF-Mei Pharma announces exclusive license agreement with Presage Biosciences for voruciclib

* Mei Pharma announces exclusive license agreement with Presage Biosciences for voruciclib, an oral, selective cdk inhibitor

BRIEF-Helsinn group and Mei Pharma announce first patient dosed in myeloid leukemia study

* Helsinn group and Mei Pharma announce first patient dosed in pivotal phase 3 study of pracinostat and azacitidine in acute myeloid leukemia Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

BRIEF-Helsinn Group and Mei Pharma announce first patient dosed in phase 2 dose-optimization study of pracinostat and azacitidine

* Helsinn group and Mei Pharma announce first patient dosed in phase 2 dose-optimization study of pracinostat and azacitidine in myelodysplastic syndrome

Select another date: